Clinical Trial Update: Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection [Phase 4]

View source ↗

Summary

Phase 4 trial results indicate that polyhexamethylene biguanide increases regression of HPV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• Polyhexamethylene Biguanide (polyhexamethylene biguanide)

Snippet

Sponsor: AGUNCO Obstetrics and Gynecology Centre | Conditions: HPV Infection | Phase 4 | Status: COMPLETED